A review: Serum Lipid Profile Status in Cardiovascular Disease
Abstract
Dyslipidemia is one of the modifiable risk factors for cardiovascular diseases (CVD). Lipids and lipoproteins, their metabolism, and their transport are essential contributing factors of cardiovascular disease (CVD) as they regulate plasma cholesterol concentration, enhancing cholesterol uptake by macrophages, leading to foam cell formation and ultimately resulting in plaque formation and inflammation. In a population with cardiovascular risk factors, HDL-cholesterol, Total/HDL-cholesterol and triglycerides/HDL-cholesterol ratios were associated with a higher population attributable risk for cardiovascular disease compared to other common biomarkers.
References
1. Hunter DJ, Reddy KS. Noncommunicable diseases. The New England Journal of Medicine 2013; 369(14): 1336–1343. doi: 10.1056/NEJMra1109345
2. World Health Organisation. Global action plan for the prevention and control of NCDs 2013–2020.
3. Tetali SS, Fricker AT, van Domburg YA, Roy I. Intelligent Biomaterials for Cardiovascular Applications. Current Opinion in Biomedical Engineering. 2023 Jun 22:100474.
4. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics–2016 update: A report from the American Heart Association. Circulation 2016; 133(4): 38–60. doi: 10.1161/CIR.0000000000000350
5. Islam SMS. Non‐communicable diseases (NCDs) in developing countries: A symposium report. Globalization and Health 2014; 10: 81. doi: 10.1186/s12992-014-0081-9
6. Ferdushi KF, Kamil AA, Hasan MN, Islam T. Factors associated with coronary heart disease among elderly people in different communities. In: Statistics for Data Science and Policy Analysis. Springer Singapore; 2020. pp. 207–219.
7. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics–2016 update: A report from the American Heart Association. Circulation 2016; 133(4): 38. doi: 10.1161/cir.0000000000000350
8. National Heart, Lung, and Blood Institute. Know the differences: cardiovascular disease, heart disease, coronary heart disease.
9. National Heart Lung and Blood Institute. Healthy Heart, Healthy Family: A community health worker’s manual for the Filipino community.
10. Grundy SM, Stone NJ, Guideline Writing Committee for the 2018 Cholesterol Guidelines†. 2018 Cholesterol clinical practice guidelines: synopsis of the 2018 American Heart Association/American College of Cardiology/Multisociety cholesterol guideline. Annals of internal medicine. 2019 Jun 4;170(11):779-83.
11. Enas EA, Chacko V, Pazhoor SG, et al. Dyslipidemia in South Asian patients. Current Atherosclerosis Reports 2007; 9(5): 367–374. doi: 10.1007/s11883-007-0047-y
12. Macwan SS, Jain V. A Study to Assess the Effectiveness of Structured Teaching Program on Knowledge and Practice Regarding Adult Cardio Pulmonary Resuscitation among Road Traffic Police in Nadiad City. Indian Journal of Forensic Medicine & Toxicology. 2021 May 17;15(3):514-9.
13. Zhang X, Patel A, Horibe H, et al. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. International Journal of Epidemiology 2003; 32(4): 563–572. doi: 10.1093/ije/dyg106
14. Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet 2014; 384(9943): 626–635. doi: 10.1016/S0140-6736(14)61177-6
15. Howard BV, Robbins DC, Sievers ML, et al. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The strong heart study. Arteriosclerosis, Thrombosis, and Vascular Biology 2000; 20(3): 830–835. doi: 10.1161/01.atv.20.3.830
16. Bharosay A, Bharosay VV, Bandyopadhyay D, et al. Effect of lipid profile upon prognosisin ischemic and haemorrhagic cerebrovascular stroke. Indian Journal of Clinical Biochemistry 2014; 29(3): 372–276. doi: 10.1007/s12291-013-0372-6
17. WHO: Global Status Report on Noncommunicable Diseases 2014. World Health Organization; 2014.
18. Das SK, Golam Faruque AS, Chowdhury AK, et al. Lipoprotein status among urban populations in Bangladesh. Atherosclerosis 2012; 223(2): 454–457. doi: 10.1016/j.atherosclerosis.2012.05.002
19. Islam N, Rahman MZ, Choudhury S, et al. Prevalence of dyslipidaemia and associated factors among the sub-urban Bangladeshi population. University Heart Journal 2012; 8(1): 15–19. doi: 10.3329/uhj. v8i1.11662
20. Zaman MM, Choudhury SR, Ahmed J, et al. Plasma lipids in a rural population of Bangladesh. European Journal of Cardiovascular Prevention and Rehabilitation 2006; 13(3): 444–448. doi: 10.1097/01.hjr.0000216544.61690.6b
21. Kumar L, Das AL. Assessment of serum lipid profile in patients of coronary artery disease: A case-control study. International Journal of Contemporary Medical Research 2018; 5(5): 59–62. doi: 10.21276/ijcmr.2018.5.5.42
22. Akanda MAK, Ali Z, Chowdhury KN, et al. Study of lipid profile in adult population of Bangladesh. Cardiovascular Journal 2016; 8(2): 128–134. doi: 10.3329/cardio. v8i2.26815
23. Haque AE, Yusoff FBM, Bin Ariffin MHS, et al. Lipid profile of the Coronary Heart Disease (CHD) patients admitted in a hospital in Malaysia. Journal of Applied Pharmaceutical Science 2016; 6(5): 137–142. doi: 10.7324/JAPS.2016.60521
24. Chowdhury KN, Mainuddin AKM, Wahiduzzaman M, Islam SMS. Serum lipid profile and its association with hypertension in Bangladesh. Vascular Health and Risk Management 2014; 10: 327–332. doi: 10.2147/VHRM.S61019
25. Ferduos BA, Sultana N, Ahmed S, et al. Serum lipid profile in ischemic heart disease: A cross-sectional analytical study. Bangladesh Journal of Medical Biochemistry 2014; 7(1): 14–16.
26. Kondredddy R, Chenak A, Akula US, et al, Study of lipid profile in coronary heart disease patients in Libya. Journal of Biomedical Sciences 2012; 1(4): 3. doi: 10.3823/1011
27. Jawalekar SL, Kulkarni UJ, Surve VT, Deshmukh YA. Status of lipid profile, MDA and protein carbonyl in patients with cardiovascular diseases. Archives of Applied Science Research 2010; 2(6): 8–14.
28. Islam S, Hossen MA, Rahman MA, Lubaba MI, Akram A. Serum uric acid level among type-2 diabetes subjects attending in a tertiary hospital of Bangladesh. World Journal of Biology Pharmacy and Health Sciences. 2022;12(1):081-5.
29. Fatema K, Rahman MA, Ahmed ANN, Paul D, Mondal BR, Islam S, Khatun DR, Akram A. Salivary Ferritin is a Diagnostic Marker in Iron Deficiency Anaemia in Children. Int. j. adv. multidisc. res. stud. 2022; 2(6):913-918.
